Literature DB >> 18377363

Ankyrin repeats-containing cofactors interact with ADA3 and modulate its co-activator function.

Chia-Wei Li1, Gia Khanh Dinh, Aihua Zhang, J Don Chen.   

Abstract

ANCO (ankyrin repeats-containing cofactor)-1 and ANCO-2 are a family of unique transcriptional co-regulators with dual properties: they interact with both the co-activators and the co-repressors [Zhang, Yeung, Li, Tsai, Dinh, Wu, Li and Chen (2004) J. Biol. Chem. 279, 33799-33805]. Specifically, ANCO-1 is thought to recruit HDACs (histone deacetylases) to the p160 co-activator to repress transcriptional activation by nuclear receptors. In the present study, we provide new evidence to suggest further that ANCO-1 and ANCO-2 also interact with the co-activator ADA3 (alteration/deficiency in activation 3). The interaction occurs between the conserved C-terminal domain of ANCO-1 and the N-terminal transactivation domain of ADA3. Several subunits of the P/CAF {p300/CBP [CREB (cAMP-response-element-binding protein)-binding protein]-associated factor} complex, including ADA3, ADA2alpha/beta and P/CAF, showed co-localization with ANCO-1 nuclear dots, indicating an in vivo association of ANCO-1 with the P/CAF complex. Furthermore, a transient reporter assay revealed that both ANCO-1 and ANCO-2 repress ADA3-mediated transcriptional co-activation on nuclear receptors, whereas ANCO-1 stimulated p53-mediated transactivation. These data suggest that ADA3 is a newly identified target of the ANCO proteins, which may modulate co-activator function in a transcription-factor-specific manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18377363     DOI: 10.1042/BJ20071484

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  5 in total

1.  Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex.

Authors:  Jason P Garee; Christopher D Chien; Jordan V Li; Anton Wellstein; Anna T Riegel
Journal:  Mol Endocrinol       Date:  2014-03-28

2.  Alteration/Deficiency in Activation 3 (ADA3) Protein, a Cell Cycle Regulator, Associates with the Centromere through CENP-B and Regulates Chromosome Segregation.

Authors:  Shakur Mohibi; Shashank Srivastava; Jun Wang-France; Sameer Mirza; Xiangshan Zhao; Hamid Band; Vimla Band
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

3.  Human ADA3 regulates RARalpha transcriptional activity through direct contact between LxxLL motifs and the receptor coactivator pocket.

Authors:  Chia-Wei Li; Ni Ai; Gia Khanh Dinh; William J Welsh; J Don Chen
Journal:  Nucleic Acids Res       Date:  2010-04-22       Impact factor: 16.971

4.  Silencing of ANKRD12 circRNA induces molecular and functional changes associated with invasive phenotypes.

Authors:  Thasni Karedath; Ikhlak Ahmed; Wafa Al Ameri; Fatima M Al-Dasim; Simeon S Andrews; Samson Samuel; Iman K Al-Azwani; Yasmin Ali Mohamoud; Arash Rafii; Joel A Malek
Journal:  BMC Cancer       Date:  2019-06-11       Impact factor: 4.430

5.  Clinical significance of Ankyrin repeat domain 12 expression in colorectal cancer.

Authors:  Rui Bai; Dan Li; Zhong Shi; Xuefeng Fang; Weiting Ge; Shu Zheng
Journal:  J Exp Clin Cancer Res       Date:  2013-05-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.